OCEAN BIOMEDICAL, INC. Research and Development Expense
OCEAN BIOMEDICAL, INC. (OCEA) reported Research and Development Expense of $18.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2025-05-15
- OCEAN BIOMEDICAL, INC. research and development expense for the quarter ending 2025-03-31 was $18.00K, a 30.77% decline year-over-year.
- OCEAN BIOMEDICAL, INC. research and development expense for the quarter ending 2024-12-31 was $0.00.
- OCEAN BIOMEDICAL, INC. research and development expense for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- OCEAN BIOMEDICAL, INC. research and development expense for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- OCEAN BIOMEDICAL, INC. research and development expense for fiscal 2024 was $26.00K, a 96.33% decline from fiscal 2023.
- OCEAN BIOMEDICAL, INC. research and development expense for fiscal 2023 was $709.00K, a 91.57% decline from fiscal 2022.
- OCEAN BIOMEDICAL, INC. research and development expense for fiscal 2022 was $8.41M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2025-03-31 | $18.00K 10-Q · filed 2025-05-15 | $18.00K derived: sum of 2 quarters · filed 2025-05-15 | $18.00K derived: sum of 3 quarters · filed 2025-05-15 | $18.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-08 | $0.00 derived: sum of 2 quarters · filed 2025-04-08 | $0.00 derived: sum of 3 quarters · filed 2025-04-08 | $26.00K 10-K · filed 2025-04-08 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-01-13 | $0.00 derived: sum of 2 quarters · filed 2025-01-13 | $26.00K 10-Q · filed 2025-01-13 | $9.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-23 | $26.00K 10-Q · filed 2024-12-23 | $9.00K derived: sum of 3 quarters · filed 2025-05-15 | $314.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-03-31 | $26.00K 10-Q · filed 2025-05-15 | $9.00K derived: sum of 2 quarters · filed 2025-05-15 | $314.00K derived: sum of 3 quarters · filed 2025-05-15 | $342.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-08 | $288.00K derived: sum of 2 quarters · filed 2025-04-08 | $316.00K derived: sum of 3 quarters · filed 2025-04-08 | $709.00K 10-K · filed 2025-04-08 |
| 2023-09-30 | $305.00K 10-Q · filed 2025-01-13 | $333.00K derived: sum of 2 quarters · filed 2025-01-13 | $726.00K 10-Q · filed 2025-01-13 | $887.00K derived: sum of 4 quarters · filed 2025-01-13 |
| 2023-06-30 | $28.00K 10-Q · filed 2024-12-23 | $421.00K 10-Q · filed 2024-12-23 | $582.00K derived: sum of 3 quarters · filed 2024-12-23 | $2.44M derived: sum of 4 quarters · filed 2024-12-23 |
| 2023-03-31 | $393.00K 10-Q · filed 2024-12-23 | $554.00K derived: sum of 2 quarters · filed 2024-12-23 | $2.41M derived: sum of 3 quarters · filed 2024-12-23 | $5.60M derived: sum of 4 quarters · filed 2024-12-23 |
| 2022-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-25 | $2.02M derived: sum of 2 quarters · filed 2024-11-25 | $5.21M derived: sum of 3 quarters · filed 2024-11-25 | $8.41M 10-K · filed 2024-11-25 |
| 2022-09-30 | $1.86M 10-Q · filed 2024-04-15 | $5.05M derived: sum of 2 quarters · filed 2024-04-15 | $8.25M 10-Q · filed 2024-04-15 | |
| 2022-06-30 | $3.19M 10-Q/A · filed 2024-04-15 | $6.39M 10-Q/A · filed 2024-04-15 | ||
| 2022-03-31 | $3.20M 10-Q/A · filed 2024-04-15 |